TY  - GEN
AU  - Andersson,P B
AU  - Waubant,E
AU  - Goodkin,D E
TI  - How should we proceed with disease-modifying treatments for multiple sclerosis?
SN  - 0140-6736
PY  - 1997///0407
KW  - Clinical Trials as Topic
KW  - Disease Progression
KW  - Glatiramer Acetate
KW  - Humans
KW  - Immunoglobulins, Intravenous
KW  - therapeutic use
KW  - Immunosuppressive Agents
KW  - Interferon beta-1a
KW  - Interferon beta-1b
KW  - Interferon-beta
KW  - Multiple Sclerosis
KW  - immunology
KW  - Peptides
N1  - Publication Type: Comment; Journal Article
UR  - https://doi.org/10.1016/S0140-6736(05)61562-0
ER  -